FDA Inspection 1266065 — Robert B. Molpus, M.D.
The FDA completed an inspection of Robert B. Molpus, M.D. on Apr 3, 2025 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 3, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Orlando, FL (United States)
Additional Details
Clinical Investigator (CI)